middle.news

How Will Osteopore’s Medprin Deal Transform Latin America’s Craniofacial Market?

9:06am on Friday 13th of February, 2026 AEDT Healthcare
Read Story

How Will Osteopore’s Medprin Deal Transform Latin America’s Craniofacial Market?

9:06am on Friday 13th of February, 2026 AEDT
Key Points
  • Exclusive 3-year distribution agreement with Medprin Biotech GmbH
  • Focus on Latin America’s craniofacial reconstruction market excluding Brazil
  • Market valued at AUD 367 million in 2023, forecast to reach AUD 509 million by 2028
  • Partnership leverages Medprin’s neurosurgery expertise and regional channels
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about OSX
OPEN ARTICLE